Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTavistock Regulatory News (TAVI)

Share Price Information for Tavistock (TAVI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.65
Bid: 3.50
Ask: 3.80
Change: 0.25 (7.35%)
Spread: 0.30 (8.571%)
Open: 3.40
High: 3.65
Low: 3.40
Prev. Close: 3.40
TAVI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of GM

20 Nov 2020 07:00

RNS Number : 8687F
Tavistock Investments PLC
20 November 2020
 

Tavistock Investments Plc

("Tavistock" or the "Company")

 

Notice of General Meeting

 

20 November 2020

 

Tavistock Investments Plc (AIM:TAVI) announces that it is convening a general meeting of the Company's shareholders (the "GM") at 11.30 am on Wednesday, 16 December 2020 at the Company's offices at 1 Bracknell Beeches, Old Bracknell Lane, Bracknell RG 12 7BW.

 

The purpose of the GM is to seek Shareholders' approval for the creation of a new class of growth shares and to make other minor amendments to the Company's Articles of Association to update them generally.

 

The Directors are looking to develop Tavistock into a significantly larger business and as a part of a wider focus on improving shareholder value, are now seeking to replace the use of share options as a means of incentivising the leadership team, including the Company's Executive Directors (being Oliver Cooke and Brian Raven) with an alternative incentive proposal that maintains the advantage of shareholders receiving the benefit of the Company's improving performance before any reward is achieved by the leadership team.

 

The accounting treatment of share options results in the Company incurring substantial share-based payment charges in its profit and loss account which adversely impact the level of its pre-tax profit. This potentially restricts the Board's ability to recommend dividend payments in the future.

 

The new proposal offers the Executive Directors and other members of the leadership team the potential of reward should they achieve more demanding performance hurdles than those attached to their current share options but also introduces peril (the risk of loss) for non-performance.

 

If the proposed arrangements are approved by shareholders and are implemented by the Board, the Executive Directors would intend to:

 

a) surrender, for nil consideration, all of the 58,200,000 share options that have been granted to them in the past; and

b) subscribe for a new class of growth shares, to be called "A Ordinary Shares", at £1 per A Ordinary Share - a price that is more than fifty times higher than the current market price of the Company's Ordinary Shares.

 

A surrender by the Executive Directors of all of their share options would trigger a reversal of the historic share-based payment charges and would result in the Company's profit before tax being enhanced by approximately £400,000 in the current financial year.

 

The Directors believe that the benefits offered to shareholders by the proposed arrangements include the following:

 

- an immediate enhancement of approximately £400,000 to the Company's pre-tax profit;

- potential further pre-tax profit enhancement as other members of the leadership team participate in the scheme; and

- a subscription of £100,000 into the Company by the Executive Directors at £1.00 per A ordinary Share.

 

For the leadership team to benefit from the proposed new arrangements they must first:

- waive the potential value of their existing share options for nil consideration;

- subscribe for A Ordinary Shares at a price that is more than fifty times higher than the current market price of the Company's Ordinary Shares; and

- achieve significantly more demanding performance targets.

 

A circular, containing details of the new incentive proposal and a formal notice convening the GM, is being sent to shareholders. A copy of the circular, together with a copy of the form of proxy, can be found on the Company's website at: https://tavistockinvestments.com/announcements.

 

Due to the current COVID-19 measures implemented by the Government in the United Kingdom SHAREHOLDERS WILL NOT BE PERMITTED TO ATTEND THE GM. The Company will ensure that the meeting is quorate and that the legal requirements are met.

 

SHAREHOLDERS WISHING TO VOTE ON THE RESOLUTION ARE STRONGLY URGED TO DO SO THROUGH COMPLETION OF THE FORM OF PROXY THAT IS BEING SENT TO THEM.

 

If shareholders have any questions or comments relating to the business of the meeting that they would like to put to the Board then they are requested to submit those questions in writing via email to GM161220@tavistockinvestmentsplc.com no later than 11.30 on 14 December 2020. The Board will publish a summary of any questions received which are of common interest, together with a written response on the Company's website as soon as practicable after the conclusion of the meeting.

 

The Board consider that the proposed incentive arrangements will be beneficial for the Company and its shareholders as a whole, and unanimously recommend that shareholders vote in favour of the resolution to be proposed at the GM, as they intend to do in respect of their aggregate shareholdings of 94,736,629 ordinary shares representing approximately 15.59% of the ordinary shares currently in issue.

 

 

Ends

 

Enquiries

Tavistock Investments Plc

Oliver Cooke

Brian Raven

Tel: 01753 867000

 

 

 

Allenby Capital Limited

Nick Naylor, Nick Athanas, Liz Kirchner (Corporate Finance)

 

Tony Quirke (Sales)

 

Tel: 020 3328 5656

 

 

Vested

Sophie Paterson

Tel: 07540 496 159

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOGKKCBDKBDDPDD
Date   Source Headline
28th Jun 202410:16 amRNSStatement re press speculation
21st Jun 202410:31 amRNSDirectorate Change
31st May 20247:00 amRNSBoard role change
8th Jan 20247:00 amRNSDirector/PDMR Shareholding
4th Jan 20249:33 amRNSDirector/PDMR Shareholding
19th Dec 20237:00 amRNSInterim Results
1st Nov 202312:25 pmRNSResult of AGM
18th Oct 20234:58 pmRNSNotice of AGM
5th Oct 20237:00 amRNSTrading update and interim dividend declaration
20th Sep 20237:00 amRNSFinal Results for Year Ended 31 March 2023
28th Apr 20235:00 pmRNSTotal Voting Rights
11th Apr 20237:00 amRNSAcquisition of Precise Protect Limited
1st Mar 20237:00 amRNSTotal Voting Rights
16th Feb 20231:45 pmRNSExercise of Options and Total Voting Rights
10th Feb 20237:00 amRNSChange of Auditor
26th Jan 20237:00 amRNSDirector appointment
20th Dec 20227:00 amRNSInterim Results
1st Dec 20227:49 amRNSSale of LEBC Hummingbird Limited
30th Nov 20225:00 pmRNSTotal Voting Rights
22nd Nov 202212:30 pmRNSBuyback shares cancelled
18th Nov 20229:30 amRNSTransaction in Own Shares
4th Nov 202211:30 amRNSExercise of Options and Total Voting Rights
31st Oct 202212:00 pmRNSResult of AGM
6th Oct 20227:00 amRNSNotice of AGM
30th Sep 20225:00 pmRNSTotal Voting Rights
28th Sep 20227:00 amRNSPosting of Annual Report and Accounts
26th Sep 20227:00 amRNSFinal Results for Year Ended 31 March 2022
2nd Sep 202212:49 pmRNSExercise of Options and Total Voting Rights
31st Aug 20225:00 pmRNSTotal Voting Rights
24th Aug 20222:14 pmRNSBuyback shares cancelled
17th Aug 202210:41 amRNSTransaction in Own Shares
16th Aug 202210:14 amRNSDirector/PDMR Shareholding
26th Jul 202211:50 amRNSDirector/PDMR Shareholding
26th Jul 202210:33 amRNSDirector/PDMR Shareholding
12th Jul 20223:42 pmRNSHolding(s) in Company
12th Jul 20221:10 pmRNSHolding(s) in Company
4th Jul 202211:56 amRNSDirector/PDMR Shareholding
30th Jun 20226:29 pmRNSTotal Voting Rights
30th Jun 20222:20 pmRNSDirector/PDMR Shareholding
29th Jun 20222:22 pmRNSDirector/PDMR Shareholding
27th Jun 20227:00 amRNSTrading update and interim dividend declaration
23rd Jun 20222:04 pmRNSExercise of Options and Total Voting Rights
23rd May 20227:00 amRNSAcquisition of LEBC Hummingbird Limited
10th May 20227:00 amRNSDirector/PDMR Shareholding
3rd May 20227:00 amRNSCompletion of purchase of minority holding in LEBC
31st Mar 20225:00 pmRNSTotal Voting Rights
21st Mar 20227:00 amRNSTotal Voting Rights & AIM Rule 17
17th Mar 20227:00 amRNSHolding(s) in Company
28th Feb 202211:06 amRNSSecond Price Monitoring Extn
28th Feb 202211:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.